01435cam2 22002891 450 SOBE0004356720220105122127.0881410150720140603d2003 |||||ita|0103 baitaIT<<3.1: >>Diritto internazionale privato, condizione e reciprocità, diritto amministrativo internazionale, diritto processuale civile internazionale, diritto tributario internazionale, diritto valutario, trustsGaetano PetrelliMilanoGiuffrè2003XXXVII, 1085 p.25 cm1 CD-ROM001SOB0060372001 Formulario notarile commentato / Gaetano Petrelli. Vol.I/II. Vol.III in 3 t.3.1Petrelli, GaetanoAF00003533070235082ITUNISOB20220105RICAUNISOBUNISOB340115714UNISOB340|CD115714.SOBE00043567M 102 Monografia moderna SBNM340003228-3.1SI115714menleUNISOBUNISOB20140603135613.020140603141651.0menle340|CD000032-3.1CON115714.acquistobethbUNISOBUNISOB20220105122050.020220105122127.0bethbDiritto internazionale privato, condizione e reciprocità, diritto amministrativo internazionale, diritto processuale civile internazionale, diritto tributario internazionale, diritto valutario, trusts1074947UNISOB03940nam 2201033z- 450 991059507610332120231214133349.0(CKB)5680000000080765(oapen)https://directory.doabooks.org/handle/20.500.12854/92063(EXLCZ)99568000000008076520202209d2022 |y 0engurmn|---annantxtrdacontentcrdamediacrrdacarrierNovel Biomarkers of Gastrointestinal CancerBaselMDPI Books20221 electronic resource (248 p.)3-0365-4932-3 3-0365-4931-5 Gastrointestinal (GI) cancer is a major cause of morbidity and mortality in the world. Since early diagnosis and optimal treatment selection are crucial to improving the prognosis of these diseases, the discovery of useful biomarkers has the potential to greatly reduce their burden. Recent technical and mechanical developments have allowed for the detection of tiny differences in various factors modified in physical conditions, which could contribute to the discovery of novel biomarkers for some diseases.In this Special Issue, we aim to focus on novel biomarkers for GI cancers, including esophageal cancer, gastric cancer, colorectal cancer, liver cancer, pancreatic cancer and biliary cancer. In addition, any samples (tissue, blood, urine and feces) are useful as biomarker sources, although body-fluid-based biomarkers are promising as diagnostic biomarkers due to their noninvasiveness. This Special Issue aims to collect novel insights clarifying the current situation and future perspective in this field.MedicinebicsscOncologybicssccolorectal canceradvanced adenomascreeningstoolmRNAcancer screeningcirrhosisAFPmachine learningMALDI-TOFproteomicsCXCR4prognosisoverall survivalrectal cancerneoadjuvant chemoradiationmouse modelbiomarkersurokinase plasminogen activator (uPA)urokinase plasminogen activator receptor (uPAR)plasminogen activator inhibitor type 1 (PAI-1)circulating tumour cell (CTC)gastric canceroesophageal cancerserine proteasestumour microenvironmentserpinsbiomarkerchemoresistanceliquid biopsymicroRNAlong non-coding RNAcolorectal neoplasmscancer screening testsearly detection of cancerprecision medicineunfolded proteinhepatocellular cancerGSVAunfolded protein scoreepigenetic regulation genessomatic mutationsmolecular genetic markersextracellular vesiclesmicrobiome16S rRNA ampliconmetagenomicsliver fibrosishepatocellular carcinomarecurrenceSHG/TPEF microscopyartificial intelligenceadvanced gastric cancertargeted therapyurinary miRNAmiR-129-1-3pmiR-566MedicineOncologyShimura Takayaedt1329046Shimura TakayaothBOOK9910595076103321Novel Biomarkers of Gastrointestinal Cancer3039266UNINA